Q4 2019 13F Holders as of 12/31/2019
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
119M
-
Number of holders
-
135
-
Total 13F shares, excl. options
-
54.3M
-
Shares change
-
+10.5M
-
Total reported value, excl. options
-
$576M
-
Value change
-
+$111M
-
Put/Call ratio
-
1.74
-
Number of buys
-
70
-
Number of sells
-
-59
-
Price
-
$10.61
Significant Holders of CYTOKINETICS INC - COMMON STOCK (CYTK) as of Q4 2019
164 filings reported holding CYTK - CYTOKINETICS INC - COMMON STOCK as of Q4 2019.
CYTOKINETICS INC - COMMON STOCK (CYTK) has 135 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 54.3M shares
of 119M outstanding shares and own 45.51% of the company stock.
Largest 10 shareholders include BlackRock Inc. (9.56M shares), BVF INC/IL (7.21M shares), VANGUARD GROUP INC (4.55M shares), DRIEHAUS CAPITAL MANAGEMENT LLC (3.04M shares), Point72 Asset Management, L.P. (3.03M shares), WASATCH ADVISORS INC (2.59M shares), MILLENNIUM MANAGEMENT LLC (2.57M shares), STATE STREET CORP (2.54M shares), Foresite Capital Management IV, LLC (2.4M shares), and FMR LLC (1.78M shares).
This table shows the top 135 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.